Waters (WAT) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Dec 11, 2025

Why Is Waters (WAT) Up 6.9% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Dec 4, 2025

Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Waters Corporation ( WAT ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Udit Batra - President, CEO & Director Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Presentation Tycho Peterson Jefferies LLC, Research Division Okay. Thank you, everybody.

Seeking Alpha • Nov 18, 2025

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography Data System (CDS). Mitigates CDS communication errors encountered in up to 70% of multi-vendor LC-CAD configurations.1 Delivers near-universal detection of an expansive range of analytes across pharmaceutical formulations, food additives, and environmental pollutants, including those that are challenging to measure using UV or mass spectrometry methods.

PRNewsWire • Nov 11, 2025

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

MILFORD, Mass. , Nov. 11, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.

PRNewsWire • Nov 11, 2025

Waters Q3 Earnings Surpass Estimates, Revenue Increase Y/Y

WAT posts strong Q3 results with 16% earnings growth and higher sales, lifting its full-year outlook for 2025.

Zacks Investment Research • Nov 5, 2025

The London Company SMID Cap Vs. Russell 2500 Q3 2025 Top Contributors And Detractors

Armstrong World Industries, Inc. (AWI) shares outperformed in the quarter due to beating expectations, driven by favorable positioning in key verticals and strong operating leverage. Somnigroup International Inc. (SGI) was a top performer as it continues to gain incremental share in the bedding market, despite the weakness in the end market. Waters Corporation (WAT) underperformed on the announcement that it will acquire Becton Dickinson's Biosciences and Diagnostics divisions.

Seeking Alpha • Nov 5, 2025

Waters Corp raises annual profit forecast on stronger lab equipment demand

Lab equipment maker Waters Corp raised its annual profit forecast on Tuesday, after beating third-quarter profit estimates on improved demand from biotech clients for its tools used in drug development and research.

Reuters • Nov 4, 2025

Waters Corporation (WAT) Q3 2025 Earnings Call Transcript

Waters Corporation ( WAT ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President, CEO & Director Amol Chaubal - Senior VP & CFO Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Jack Meehan - Nephron Research LLC Puneet Souda - Leerink Partners LLC, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Douglas Schenkel - Wolfe Research, LLC Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Brandon Couillard - Wells Fargo Securities, LLC, Research Division Presentation Operator Welcome to the Waters Corporation's Third Quarter 2025 Financial Results Conference Call.

Seeking Alpha • Nov 4, 2025

Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results

Highlights Sales of $800 million exceeded guidance; grew 8% as reported and 8% in constant currency Delivered GAAP EPS of $2.50 and non-GAAP EPS of $3.40, which reflects strong, 16% growth in Adjusted Earnings Per Share that exceeded guidance Instruments grew 6% in constant currency, led by high single-digit LC & MS growth, and TA Division returning to positive growth Recurring revenue grew 9% in constant currency; chemistry grew double digits, with strong uptake of new bioseparations products In constant currency, Pharma grew 11%, driven by broad-based growth across all regions, including double-digit growth in the Americas Raising full-year 2025 constant currency sales growth guidance and raising full-year 2025 non-GAAP EPS guidance Third Quarter 2025 MILFORD, Mass. , Nov. 4, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT), today announced its financial results for the third quarter of 2025.

PRNewsWire • Nov 4, 2025